Short-term results of the efficacy of percutaneous tibial nerve stimulation on urinary symptoms and its financial cost
Short-term results of the efficacy of percutaneous tibial nerve stimulation on urinary symptoms and its financial cost is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Short-term results of the efficacy of percutaneous tibial nerve stimulation on urinary symptoms and its financial cost have?
Short-term results of the efficacy of percutaneous tibial nerve stimulation on urinary symptoms and its financial cost has 5 citations in the OpenAlex counts ScholarIQ stores.
When was Short-term results of the efficacy of percutaneous tibial nerve stimulation on urinary symptoms and its financial cost published?
Short-term results of the efficacy of percutaneous tibial nerve stimulation on urinary symptoms and its financial cost has 2018 year in the ScholarIQ index.
What is the open-access status of Short-term results of the efficacy of percutaneous tibial nerve stimulation on urinary symptoms and its financial cost?
Short-term results of the efficacy of percutaneous tibial nerve stimulation on urinary symptoms and its financial cost has diamond oa status in the ScholarIQ index.
What is the DOI of Short-term results of the efficacy of percutaneous tibial nerve stimulation on urinary symptoms and its financial cost?
The DOI for Short-term results of the efficacy of percutaneous tibial nerve stimulation on urinary symptoms and its financial cost is on the source record.
What is the PMID of Short-term results of the efficacy of percutaneous tibial nerve stimulation on urinary symptoms and its financial cost?
The PMID for Short-term results of the efficacy of percutaneous tibial nerve stimulation on urinary symptoms and its financial cost is on the source record.
What is the OpenAlex record for Short-term results of the efficacy of percutaneous tibial nerve stimulation on urinary symptoms and its financial cost?
The OpenAlex for Short-term results of the efficacy of percutaneous tibial nerve stimulation on urinary symptoms and its financial cost is on the source record.